Prothya Biosolutions Belgium

Brussel ·KBO/BCE: BE 0462.229.645

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	08-07-2025	23 d early	2025-00251881
31-12-2023	31-07-2024	17-07-2024	14 d early	2024-00258503
31-12-2022	31-07-2023	27-09-2023	58 d late	2023-00459015
31-12-2021	31-07-2022	26-07-2022	5 d early	2022-20238631
31-12-2020	31-07-2021	20-07-2021	11 d early	2021-37100345
31-12-2019	31-07-2020	14-05-2020	78 d early	2020-12000391
31-12-2018	31-07-2019	14-05-2019	78 d early	2019-12900339

Metric	This company	Sector median	Position in the sector
Solvency	14.5%	46.9%	better than 33% of 46 sector peers
Net result	€-1.51M	€-1k	better than 9% of 46 sector peers
Equity	€23.83M	€108k	better than 93% of 46 sector peers
Total assets	€163.91M	€284k	better than 95% of 46 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€163.91M
Fixed assets	21/28	€55.84M
Intangible fixed assets	21	€2.39M
Tangible fixed assets	22/27	€18.87M
Financial fixed assets	28	€34.58M
Current assets	29/58	€108.07M
Stocks & contracts in progress	3	€14.15M
Amounts receivable within one year	40/41	€66.18M
Investments	50/53	€25.45M
Cash & bank	54/58	€1.07M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€163.91M
Equity	10/15	€23.83M
Contributions / capital	10/11	€1.41M
Reserves	13	€25.45M
Accumulated profits (losses)	14	€-3.03M
Provisions & deferred taxes	16	€511k
Amounts payable	17/49	€139.57M
Amounts payable after one year	17	€66.88M
Amounts payable within one year	42/48	€70.93M
Trade debts payable within one year	44	€12.33M
Income statement
Turnover	70	€116.84M
Operating result	9901	€3.07M
Financial income	75	€634k
Financial charges	65	€5.17M
Result before taxes	9903	€-1.46M
Income taxes	67/77	€47k
Net result for the period	9904	€-1.51M
Result to be appropriated	9905	€-1.51M

Summary

Statutory auditor	IRE/IBR number	Tenure
BDO Bedrijfsrevisoren bvCurrent Statutory auditor · represented by Rodrigo Abels	-	15-05-2023 → present
PricewaterhouseCoopers Bedrijfsrevisoren BCVBA Statutory auditor · represented by Kevin Veestraeten succeeded by BDO Bedrijfsrevisoren bv in 2023	-	07-06-2016 → 15-05-2023

NACE primary	Vervaardiging van farmaceutische grondstoffen(21100)
Legal form	Private limited company(610)
Incorporation	24-12-1997
Status	Active
Postal code	1120

Parcel (capakey)	Region	Area	Buildings	Height / fl.
42004A0292/00Z000	Flanders	5.1 ha	1 · 2.2 ha	24.7 m · 3 fl.
21819A0044/02E000	Brussels	4,958 m²	1 · 985 m²	9.2 m · 2 fl.

Legal nameNL	Prothya Biosolutions Belgium
AbbreviationNL	“Prothya” of “Prothya Biosolutions”